A new guide to the WTO will help doctors to prevent fractures and save costs to the health system

The document has been prepared by the College medical organization and has the support of the Ministry of health, Social Affairs and equal

fragility fractures involve a high cost (up to 11,000 euros) to the health system and its consequences in women after menopause significantly affect their quality of life. With the help of the Guide to good clinical practice in Osteoporosis Postmenopáusica. Prevention of fragility fractures ”, published by the College medical organization (WTO) and presented yesterday, your primary care doctor may prevent fractures by fragility in a practical and simple way

the objective of these guidelines, in addition to helping the formation of the physician to promote the decision-making process and improve the quality of careIt is to help save costs to our health care system. All prevention helps to reduce costs and in the case of fractures by osteoporosis, these can be up 11,000 euros for our health care system ”.

Madrid, September of 2011. Yesterday presented the Guide to good clinical practice in Osteoporosis Postmenopáusica. Prevention of fragility fractures ”, a document created with the aim of updating the knowledge of medical professionals and guide them in the management of these patients.

As highlighted by the Coordinator of this guide and Treasurer of the Medical College Organization (WTO), Dr. José María Rodríguez Vicente, the objective of this guide, in addition to helping the formation of the physician to promote the decision-making process and improve the quality of careIt is to help save costs to our health care system. All prevention helps to reduce costs and in the case of fractures by osteoporosis, these can be up 11,000 euros for our health care system ”.

While this is a bone disease that can affect both men and women, these are people her with greater due mainly to the reduction in estrogen associated with the arrival of the climacteric. Thus, only Spain estimates affecting 35% of women over 50 years and 52 per cent of those who have already fulfilled the 70.

As familiar with their high incidence, family physicians and gynaecologists have worked together in this new document, drawn up by the College medical organization (WTO), with the support of the Ministry of health, Social policy and equality and the collaboration of Pfizer and Almirall. Hope that this eminently practical guide will help the professional to the decision-making process, providing it accurately and schematic options of diagnostic and therapeutic attitudes based on scientific evidence and criteria only professionals ”, explains Dr. Jose Maria Rodriguez Vicente.

To provide a truly practical guide, its more than 100 pages address the problem of this disease of high prevalence from a realistic perspective. We have teamed up with the clinical, health and social context in which we operate, and what we would like with this guide is improving the efficiency of resources and control costs, while maintaining the quality of care, in one of the diseases most prevalent in our times, such as fragility fractures ”, says Dr. Santiago Palacios, President of the Iberoamerican society of osteology and Mineral bone metabolism (SIBOMM).

The pharmacological option appropriate to the patient

One of the purposes of the new text, is to update the knowledge of physicians about new treatments antiosteoporóticos. In doing so, addresses pharmacological options that have been recently approved and carried out a review of the characteristics of all of them, as it is the case of bazedoxifeno, a new modulator selective of the receptors of estrogen (SERMS). In addition, extends this information exposing other avenues of treatment, such as bisphosphonates, strontium ranelate, the denosumab or calcium and vitamin D.

The Guide’s authors warn of the advantages and risks associated with each of them, as well as specify what is the most recommended depending on the characteristics of the patient attending the consultation.

On osteoporosis

Osteoporosis, which literally means porous bone ”, is a metabolic bone disease in which bone density and quality have become weaker, in such a way that increases the risk of fracture. Bone loss occurs as quiet ” and progressive, so usually no symptoms until occurs the first fracture, hence the importance of early detection and treatment. The most common fractures associated with osteoporosis are the wrist, hip and vertebral, while those who have more serious consequences for health are these last two.

It is estimated that it affects 75 million people in Europe, United States and Japan. Overall, in the year 2000 the osteoporosis caused around 9 million bone fractures in men and women with 50 or more years of age, of whom 3.12 million occurred in European population. In addition, it is in the years immediately after menopause when there is a greater risk, since at that time it can produce up to 20% loss of bone mass that will experience a woman in his life.

The treatment of postmenopausal osteoporosis may significantly improve the health of millions of people around the world and reduce the health and social costs associated with this pathology.